
Opinion|Videos|September 30, 2025
Understanding the Clinical Needs and Real-World Data in BCG-Unresponsive NMIBC
Author(s)Max Kates, MD
An expert discusses how BCG-unresponsive NMIBC patients have heterogeneous clinical needs requiring individualized treatment strategies, while P&T committees evaluate new therapies by assessing unmet needs and comparing real-world evidence across single-arm trials.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Providence CMO Rex Hoffman, M.D., MBA, reflects on building a career in healthcare leadership
2
Some employers steer workers toward cash platforms for GLP-1 obesity drugs
3
Trade group for transparent PBMs has changed its name
4
Animal research finds investigational drug disrupts MASH by targeting gut-liver axis
5




























